Surveying Chemosensory Dysfunction in COVID-19

被引:6
|
作者
Green, Barry G. [1 ,2 ]
机构
[1] John B Pierce Lab, 290 Congress Ave, New Haven, CT 06519 USA
[2] Yale Sch Med, Dept Surg Otolaryngol, 333 Cedar St, New Haven, CT 06511 USA
关键词
chemesthesis; COVID-19; human; olfaction; taste; PERCEPTION; CONGRUENCY; TASTE;
D O I
10.1093/chemse/bjaa048
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Soon after the outbreak of COVID-19, reports that smell and taste are disrupted by the illness drew the attention of chemosensory scientists and clinicians throughout the world. While other upper respiratory viruses are known to produce such disruptions, their occurrence with the deadly and highly infectious SARS-CoV-2 virus raised new questions about the nature of the deficits, their cause, and whether they might serve as indicators of the onset of the disease. Published in the July and August 2020 issues of Chemical Senses are 2 innovative, large-scale survey studies that were quickly devised and launched by separate multinational groups to address these questions in olfaction, taste, and chemesthesis. The surveys, which took different approaches and had somewhat different goals, add significant new data on the incidence and severity of smell loss in COVID-19, and the potential for olfactory dysfunction to serve as an indicator of the spread and severity of the disease. Less definitive evidence of the frequency, characteristics, and magnitude of disruptions in taste and chemesthesis point to the need for future survey studies that combine and refine the strengths of the present ones, as well as clinical studies designed to selectively measure deficits in all 3 chemosensory systems.
引用
收藏
页码:509 / 511
页数:3
相关论文
共 50 条
  • [21] Decreasing Incidence of Chemosensory Changes by COVID-19 Variant
    Coelho, Daniel H.
    Reiter, Evan R.
    French, Evan
    Costanzo, Richard M.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 168 (04) : 704 - 706
  • [22] Are Multiple Chemosensory Systems Accountable for COVID-19 Outcome?
    Caretta, Antonio
    Mucignat-Caretta, Carla
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [23] Taste and smell as chemosensory dysfunctions in COVID-19 infection
    Passarelli, Pier Carmine
    Lopez, Michele Antonio
    Bonaviri, Giuseppe Niccolo Mastandrea
    Garcia-Godoy, Franklin
    D'Addona, Antonio
    [J]. AMERICAN JOURNAL OF DENTISTRY, 2020, 33 (03): : 135 - 137
  • [24] Prolonged complaints of chemosensory loss after COVID-19
    Fjaeldstad, Alexander Wieck
    [J]. DANISH MEDICAL JOURNAL, 2020, 67 (08):
  • [25] Chemosensory Systems in COVID-19: Evolution of Scientific Research
    Veronese, Sheila
    Sbarbati, Andrea
    [J]. ACS CHEMICAL NEUROSCIENCE, 2021, 12 (05): : 813 - 824
  • [26] Chemosensory disorders in Covid-19: Pathomechanisms and clinical relevance
    Isenmann, Stefan
    Haehner, Antje
    Hummel, Thomas
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2021, 89 (06) : 281 - 288
  • [27] Nonplus from COVID-19 Vaccination: Chemosensory Recovery
    Plaza, Augusto Aliaga
    Basi, Tajindar K.
    Hirsch, Alan R.
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S121 - S121
  • [28] Persistent chemosensory dysfunction in COVID-19 patients: a deep dive into the psychophysical and genetic characterisation of an Italian cohort
    Spedicati, Beatrice
    Nardone, Giuseppe Giovanni
    Santin, Aurora
    Morgan, Anna
    Concas, Maria Pina
    Tirelli, Giancarlo
    Gasparini, Paolo
    Boscolo-Rizzo, Paolo
    Girotto, Giorgia
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 706 - 706
  • [29] Olfactory dysfunction and COVID-19
    Wan, Yi-Min
    Deng, Xiao
    Tan, Eng-King
    [J]. LANCET PSYCHIATRY, 2020, 7 (08): : 663 - 663
  • [30] Thyroid dysfunction in COVID-19
    David Tak Wai Lui
    Chi Ho Lee
    Yu Cho Woo
    Ivan Fan Ngai Hung
    Karen Siu Ling Lam
    [J]. Nature Reviews Endocrinology, 2024, 20 : 336 - 348